Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027646
Filing Date
2024-11-25
Accepted
2024-11-25 17:12:40
Documents
1
Period of Report
2024-11-21

Document Format Files

Seq Description Document Type Size
1 form4-11252024_101137.html 4  
1 form4-11252024_101137.xml 4 6157
  Complete submission text file 0001415889-24-027646.txt   7619
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Issuer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O DBV TECHNOLOGIES S.A. 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address
Boucinha Virginie (Reporting) CIK: 0001999496 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36697 | Film No.: 241497025